Amoena USA Corporation
Classification
Private
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
About
About
Amoena USA Corporation is a medical products company and subsidiary of the global Amoena Group, which was founded in 1975 by Cornelius Rechenberg. Rechenberg, a plastics engineering student, developed the world's first silicone breast form as a superior alternative to the fabric and rubber bra fillers available at the time. The United States subsidiary was established in Atlanta, Georgia, in 1978 and currently maintains its headquarters in Kennesaw, Georgia. Throughout its history, the company has undergone significant corporate changes, including a 1994 merger with the Breast Care Division of Coloplast A/S DK and later acquisitions by Granville Baird Capital Partners in 2007 and Halder in 2014. Business/Product Breakdown Amoena USA Corporation specializes in the design, manufacture, and distribution of breast care solutions, focusing on products that restore body symmetry and support the healing process for women who have undergone breast surgery. The company's core product line includes various generations of silicone breast forms, ranging from weighted prostheses to lightweight options and the Contact self-adhesive breast form that adheres directly to the skin. Its "Amoena Solution" framework extends beyond prosthetics to offer comprehensive recovery care, including post-surgical compression bras, scar therapy textiles, and silicone patches designed to stabilize surgical areas and improve scar texture. In addition to medical devices, the company produces a wide range of specialized apparel featuring integrated pockets to securely hold breast forms or partial shapers. This apparel line encompasses pocketed lingerie, swimwear, and leisure wear tailored to accommodate the physical changes resulting from mastectomies, lumpectomies, or breast reconstructions. The company also incorporates proprietary technologies into its products, such as Comfort+ temperature-equalizing material to reduce perspiration and Adapt Air technology, which utilizes an integrated air chamber for adjustable volume and a personalized fit.
Keywords
Keywords
Classified
Private